A Tumor Progression Model for Hepatocellular Carcinoma: Bioinformatic Analysis of Genomic Data

Gastroenterology

Volumn 131, Issue 4, 2006, Pages 1262-1270

  Poon, Terence C W ^a,b   Wong, Nathalie ^a   Lai, Paul B S ^a   Rattray, Magnus ^b   Johnson, Philip J ^c   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BIOINFORMATICS; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME 3Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EVOLUTION; FEMALE; GENETIC ASSOCIATION; GENOMICS; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 33749359258     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.08.014     Document Type: Article

References (36)

1. Debernardi S., Lillington D., and Young B.D. Understanding cancer at chromosome level: 40 years of progress. Eur J Cancer 40 (2004) 1960-1967
2. Hoglund M., Gisselsson D., Mandahl N., Johansson B., Mertens F., Mitelman F., and Sall T. Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes Chrom Cancer 31 (2001) 156-171
3. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
4. Okuda K. Hepatocellular carcinoma. J Hepatol 32 (2000) 225-237
5. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 (1988) 1942-1956
6. Dopazo J., and Carazo J.M. Phylogenetic reconstruction using an unsupervised growing neural network that adopts the topology of a phylogenetic tree. J Mol Evol 44 (1997) 226-233
7. Herrero J., Valencia A., and Dopazo J. A hierarchical unsupervised growing neural network for clustering gene expression patterns. Bioinformatics 17 (2001) 126-136
8. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., and Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10 (1994) 231-243
9. Wong N., Lai P., Lee S.W., Fan S., Pang E., Liew C.T., Sheng Z., Lau J.W., and Johnson P.J. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 154 (1999) 37-43
10. Mitelman F. ISCN (1995): an international system for human cytogenetic nomenclature (1995), S. Karger, Basel
11. Broduer G.M., Tsiatis A., William D.L., Luthardt F.W., and Green A.A. Statistical analysis of cytogenetic abnormalities in human cancer cells. Cancer Genet Cytogenet 7 (1982) 137-152
12. Jiang F., Desper R., Papadimitrious C.H., Schaffer A.A., Kallioniemi O.P., Richter J., Schraml P., Sauter G., Mihatsch M.J., and Moch H. Construction of evolution tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 60 (2000) 6503-6509
13. Baudis M., and Cleary M.L. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 17 (2001) 1228-1229
14. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov Am Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003) 374-378
15. Henderson J.M., Sherman M., Tavill A., Abecassis M., Chejfec G., and Gramlich T. A common staging system for hepatocellular carcinoma. Hepatology 39 (2004) 550-551
16. Bruix J., and Llovet J.M. Prognostic prediction in HCC: did anybody expect it to be easy?. Hepatology 39 (2004) 551-552
17. Colombo M., and Sangiovanni A. The strategic role of staging in the treatment of HCC. Comments. Hepatology 39 (2004) 552-553
18. Hoglund M., Gisselsson D., Hansen G.B., White V.A., Sall T., Mitelman F., and Horsman D. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer 108 (2004) 57-62
19. Zondervan P.E., Wink J., Alers J.C., Ijzermans J.N., Schalm S.W., de Man R.A., and van Dekken H. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasia. J Pathol 192 (2000) 207-215
20. Marchio A., Terris B., Meddeb M., Pineau P., Duverger A., Tiollais P., Bernheim A., and Dejean A. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridization. J Clin Pathol: Mol Pathol 54 (2001) 270-274
21. Tornillo L., Carafa V., Sauter G., Moch H., Minola E., Gambacorta M., Vecchione R., Bianchi L., and Terracciano L.M. Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest 82 (2002) 547-553
22. Longerich T., Breuhahn K., Odenthal M., Petmecky K., and Schirmacher P. Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma. Virchows Arch 445 (2004) 589-596
23. Hirasaki S., Koide N., Ujike K., Shinji T., and Tsuji T. Expression of Nov, CYR61 and CTGF genes in human hepatocellular carcinoma. Hepatol Res 19 (2001) 294-305
24. Terradillos O., Billet O., Renard C.A., Levy R., Molina T., Briand P., and Buendia M.A. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14 (1997) 395-404
25. Lakhtakia R., Kumar V., Reddi H., Mathur M., Dattagupta S., and Panda S.K. Hepatocellular carcinoma in a hepatitis B "x" transgenic mouse model: a sequential pathological evaluation. J Gastroenterol Hepatol 18 (2003) 80-91
26. Midorikawa Y., Tsutsumi S., Nishimura K., Kamimura N., Kano M., Sakamoto H., Makuuchi M., and Aburatani H. Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma. Cancer Res 64 (2004) 7263-7270
27. Kao Y.R., Shih J.Y., Wen W.C., Ko Y.P., Chen B.M., Chan Y.L., Chu Y.W., Yang P.C., Wu C.W., and Roffler S.R. Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res 9 (2003) 2807-2816
28. Chang Y.W., Chen S.C., Cheng E.C., Ko Y.P., Lin Y.C., Kao Y.R., Tsay Y.G., Yang P.C., Wu C.W., and Roffler S.R. CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells. Int J Cancer 116 (2005) 243-252
29. Batlle E., Henderson J.T., Beghtel H., van den Born M.M., Sancho E., Huls G., Meeldijk J., Robertson J., van de Wetering M., Pawson T., and Clevers H. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/epherinB. Cell 111 (2002) 251-263
30. Chaib H., Cockrell E.K., Rubin M.A., and Macoska J.A. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. Neoplasia 3 (2001) 43-52
31. Schwartz D.R., Wu R., Kardia S.L., Levin A.M., Huang C.C., Shedden K.A., Kuick R., Misek D.E., Hanash S.M., Taylor J.M., Reed H., Hendrix N., Zhai Y., Fearon E.R., and Cho K.R. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res 63 (2003) 2913-2922
32. Zimmermann U., Feneux D., Mathey G., Gayral F., Franco D., and Bedossa P. Chromosomal aberrations in hepatocellular carcinomas: relationship with pathological features. Hepatology 26 (1997) 1492-1498
33. Wong N., Lai P., Lee S.W., Fan S., Pang E., Liew C.T., Zhong S., Lau J.W.Y., and Johnson P.J. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis. Am J Pathol 154 (1999) 37-43
34. Kusano N., Shiraishi K., Kubo K., Oga A., Okita K., and Sasaki K. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 29 (1999) 1858-1862
35. Bouchard M.J., and Schneide R.J. The enigmatic X gene of hepatitis B virus. J Virol 78 (2004) 12725-12734
36. McGlynn K.A., Edmonson M.N., Michielli R.A., Thomas London W., Lin W.Y., Chen G.C., Shen F.M., and Buetow K.H. A phylogenetic analysis identifies heterogeneity among hepatocellular carcinoma. Hepatology 36 (2002) 1341-1348